ARA-290
An EPO-derivative peptide studied for nerve repair and inflammation.
Overview
ARA-290 is a synthetic peptide derived from erythropoietin (EPO) that has been engineered to retain EPO's tissue-protective properties while eliminating its blood-cell-stimulating effects. It is researched for its regenerative and anti-inflammatory effects, particularly on the nervous system.
Dosing
Injection
- Starting dose
- 2 mg
- Common dose
- 2–4 mg
- Frequency
- 3× weekly
- Notes
- Clinical trials used 4 mg three times weekly (subQ).
Reported research/reference doses for educational purposes only. Always verify against primary literature and applicable regulations. Not medical advice.
How it works
ARA-290 specifically activates the EPO receptor complex associated with tissue protection, reducing inflammation and apoptosis (cell death) without promoting red blood cell production. This supports nerve regeneration and reduces neuropathic pain.
Common research uses
- Nerve repair and neuropathy research
- Inflammation reduction
- Chronic pain research
- Tissue-protective signaling studies
Considerations
Research compound. Promising early clinical data for neuropathy but not yet widely approved. Research use only.